MDA Ltd.
TSX:MDA.TO
21.81 (CAD) • At close October 22, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 242 | 209.1 | 205 | 204.7 | 196 | 201.9 | 186.1 | 172 | 154.7 | 128.4 | 115.5 | 111.3 | 126.7 | 123.4 | 100.2 | 98.4 | 97 |
Cost of Revenue
| 187.4 | 163.5 | 158.9 | 147 | 134.7 | 134.7 | 127.2 | 115.6 | 103.3 | 66.7 | 70.1 | 71.9 | 82.1 | 85 | 113.8 | 67.9 | 67 |
Gross Profit
| 54.6 | 45.6 | 46.1 | 57.7 | 61.3 | 67.2 | 58.9 | 56.4 | 51.4 | 61.7 | 45.4 | 39.4 | 44.6 | 38.4 | -13.6 | 30.5 | 30 |
Gross Profit Ratio
| 0.226 | 0.218 | 0.225 | 0.282 | 0.313 | 0.333 | 0.316 | 0.328 | 0.332 | 0.481 | 0.393 | 0.354 | 0.352 | 0.311 | -0.136 | 0.31 | 0.309 |
Reseach & Development Expenses
| 19.7 | 17.1 | 22.8 | 10.4 | 10.3 | 10.1 | 7.8 | 7.8 | 8.7 | 8.5 | 8.3 | 7.5 | 3 | 2.3 | 2.6 | 2.6 | 0.6 |
General & Administrative Expenses
| 15 | 12.5 | 14 | 12.5 | 10.6 | 10.4 | 12.8 | 11.8 | 8.8 | 10 | 12.8 | 11.5 | 9.9 | 11.7 | 17.4 | 9 | 9.8 |
Selling & Marketing Expenses
| 8.7 | 8.9 | 7.6 | 8.1 | 10.1 | 7.4 | 6.6 | 6.2 | 6.4 | 5.9 | 8.2 | 5.9 | 5.8 | 6 | 7 | 6.2 | 5.8 |
SG&A
| 23.7 | 21.4 | 21.6 | 20.6 | 20.7 | 17.8 | 19.4 | 18 | 15.2 | 15.9 | 21 | 17.4 | 15.7 | 17.7 | 24.4 | 15.2 | 15.6 |
Other Expenses
| 0.1 | 6.5 | 0 | 0 | 0 | 12.8 | 12.8 | 12.8 | 12.9 | 14 | -0.1 | 4.8 | 0.9 | 3.5 | -36.6 | -1.2 | -14.9 |
Operating Expenses
| 43.4 | 38.5 | 44.4 | 42 | 42 | 40.7 | 40 | 38.6 | 36.8 | 38.4 | 42.5 | 29.7 | 28.7 | 23.5 | -9.6 | 21.4 | 7.6 |
Operating Income
| 11.2 | 7.1 | 1.7 | 15.7 | 19.3 | 26.5 | 18.9 | 17.8 | 14.6 | 23.3 | 2.1 | 0.6 | 11.1 | 14.9 | 12.1 | -2 | 0.3 |
Operating Income Ratio
| 0.046 | 0.034 | 0.008 | 0.077 | 0.098 | 0.131 | 0.102 | 0.103 | 0.094 | 0.181 | 0.018 | 0.005 | 0.088 | 0.121 | 0.121 | -0.02 | 0.003 |
Total Other Income Expenses Net
| -7.6 | 4.3 | -2.6 | 1.6 | -2.4 | -2.3 | -5.4 | 3.5 | -26.7 | -11.8 | -0.1 | 4.4 | 0.7 | -4.9 | -3.5 | 1.2 | -13.6 |
Income Before Tax
| 3.6 | 11.4 | -0.9 | 14.9 | 14.8 | 24.2 | 13.5 | 21.3 | -12.1 | 11.5 | 0.6 | 8.4 | 2.7 | -0.4 | -16.2 | -2.6 | 1 |
Income Before Tax Ratio
| 0.015 | 0.055 | -0.004 | 0.073 | 0.076 | 0.12 | 0.073 | 0.124 | -0.078 | 0.09 | 0.005 | 0.075 | 0.021 | -0.003 | -0.162 | -0.026 | 0.01 |
Income Tax Expense
| -7.4 | -2.4 | -14.4 | 5.6 | 4.9 | 8.1 | 4.7 | 3.4 | -3.3 | 3.1 | 2.2 | 4.4 | 2.8 | 1.2 | -3.6 | -0.7 | 3.8 |
Net Income
| 11 | 13.8 | 13.5 | 9.3 | 9.9 | 16.1 | 8.8 | 17.9 | -8.8 | 8.4 | 0.6 | 4 | -0.1 | -1.6 | -12.6 | -1.9 | -2.8 |
Net Income Ratio
| 0.045 | 0.066 | 0.066 | 0.045 | 0.051 | 0.08 | 0.047 | 0.104 | -0.057 | 0.065 | 0.005 | 0.036 | -0.001 | -0.013 | -0.126 | -0.019 | -0.029 |
EPS
| 0.092 | 0.12 | 0.11 | 0.078 | 0.083 | 0.14 | 0.074 | 0.15 | -0.074 | 0.071 | -0.014 | 0.03 | -0.001 | -0.014 | -0.11 | -0.067 | -0.098 |
EPS Diluted
| 0.089 | 0.11 | 0.11 | 0.076 | 0.082 | 0.13 | 0.074 | 0.15 | -0.072 | 0.068 | -0.013 | 0.03 | -0.001 | -0.014 | -0.11 | -0.067 | -0.098 |
EBITDA
| 33.7 | 29.9 | 22.6 | 35.5 | 37.3 | 45.9 | 38 | 36.4 | 33.3 | 43.1 | 22.9 | 29.4 | 37.3 | 34.4 | 31.1 | 29.5 | 25.2 |
EBITDA Ratio
| 0.139 | 0.143 | 0.11 | 0.173 | 0.19 | 0.227 | 0.204 | 0.212 | 0.215 | 0.336 | 0.198 | 0.264 | 0.294 | 0.279 | 0.31 | 0.3 | 0.26 |